# Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

> **NCT00002905** · PHASE2 · UNKNOWN · sponsor: **Centro di Riferimento Oncologico - Aviano** · enrollment: 20 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** didanosine
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** mitoxantrone hydrochloride
- **DRUG:** prednimustine
- **DRUG:** zidovudine

## Key facts

- **NCT ID:** NCT00002905
- **Lead sponsor:** Centro di Riferimento Oncologico - Aviano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1995-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002905, "Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00002905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*